Rohit Batta
Corporate Officer/Principal at Royal College of General Practitioners
Network origin in Rohit Batta first degree
Entity | Entity type | Industry | |
---|---|---|---|
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings.
15
| Non-Profit Organization | Other Consumer Services | 15 |
Faculty of Pharmaceutical Medicine
13
| Private Company | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rohit Batta via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Chief Tech/Sci/R&D Officer | |
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
OXFORD BIOMEDICA PLC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ALLIANCE PHARMA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Manchester | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
University of Wales (Bangor) | College/University | Graduate Degree | |
The University of Edinburgh | College/University | Undergraduate Degree Doctorate Degree | |
EPA EURO PHARMA Auftragsforschung GmbH
EPA EURO PHARMA Auftragsforschung GmbH Miscellaneous Commercial ServicesCommercial Services Part of Pegasus Topco Ltd., EPA EURO PHARMA Auftragsforschung GmbH is a German company that provides contract research services for the pharmaceutical industry. The company is based in Kronberg im Taunus, Germany. EPA EURO PHARMA Auftragsforschung was acquired by Premier Research Group Ltd., part of Pegasus Topco Ltd. from June 09, 2008 on June 07, 2005 for $9 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University College London | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
PharmaPart AG
PharmaPart AG Miscellaneous Commercial ServicesCommercial Services Part of P Farmaceutici SAS di Canio Giovanni Mazzaro & C., PharmaPart AG provides contract research and consultancy services for the pharmaceutical industry. The company is based in Thalwil, Switzerland. PharmaPart was acquired by P Farmaceutici SAS di Canio Giovanni Mazzaro & C. on July 13, 2005. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree | |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BIOXXMED AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
DIUL GROUP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Methodist Le Bonheur Healthcare
Methodist Le Bonheur Healthcare Hospital/Nursing ManagementHealth Services Methodist Le Bonheur Healthcare engages in management of hospitals and provision of healthcare services. It offers services in the areas of cancer care; emergency medicine; hospice care; neurology and neurosurgery; pediatrics; transplant; cardiology; employee assistance program; imaging and diagnostic services; orthopedics; primary care; and women’s health. The company was founded by John Sherard Sr. in 1918 and is headquartered in Memphis, TN. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Peterborough & Stamford Hospitals NHS Foundation Trust
Peterborough & Stamford Hospitals NHS Foundation Trust Medical/Nursing ServicesHealth Services Peterborough & Stamford Hospitals NHS Foundation Trust provides healthcare services. The company was founded on April 1, 2004 and is headquartered in Bretton, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Innovia Technology Ltd.
Innovia Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Innovia Technology Ltd. is a British innovation consultancy company founded in 1999. The private company is based in Cambridge, UK. The company operates in the field of innovation and provides consultancy services. | Miscellaneous Commercial Services | Director/Board Member | |
PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cambridge Judge Business School | College/University | Masters Business Admin | |
ERGOMED | Miscellaneous Commercial Services | President | |
Cardiff University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal | |
HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RAIN ONCOLOGY INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ENGENE HOLDINGS INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistics
International
United Kingdom | 18 |
United States | 17 |
Germany | 6 |
Canada | 4 |
Denmark | 3 |
Sectoral
Health Technology | 24 |
Consumer Services | 10 |
Commercial Services | 9 |
Health Services | 5 |
Process Industries | 3 |
Operational
Corporate Officer/Principal | 86 |
Director/Board Member | 81 |
Chief Tech/Sci/R&D Officer | 54 |
Chief Executive Officer | 18 |
Independent Dir/Board Member | 17 |
Most connected contacts
Insiders | |
---|---|
Martin Edwards | 38 |
Cameron Durrant | 25 |
Paul Blake | 23 |
Junaid Bajwa | 18 |
Joanna Horobin | 15 |
Brian Dickson | 15 |
Richard Bryce | 15 |
Colin Broom | 12 |
Dominic Smethurst | 11 |
Wilfried Hauke | 10 |
Graham Rich | 9 |
David Jackson | 9 |
Keith Bragman | 8 |
Ado Mohammed | 8 |
Robert J. Dow | 7 |
- Stock Market
- Insiders
- Rohit Batta
- Company connections